Activation of the complement system is thought to be involved in the development of hypertension and target-organ damage. Now, Xiao-Hui Chen and colleagues report that complement 3a receptor (C3aR) and complement 5a receptor (C5aR) contribute to blood pressure regulation by modulating regulatory T (Treg) cell functions.
In wild-type mice, the researchers show that angiotensin II (ANGII) infusion induced an increase in blood pressure, a decrease in the percentage of forkhead box protein P3 (FOXP3)+ Treg cells in the kidneys and blood, and a significant upregulation of C3aR and C5aR expression in FOXP3+ Treg cells. These effects were abrogated in mice with double knockout of C3aR and C5aR (DKO mice). ANGII-induced renal damage and vascular injury were also attenuated in DKO mice compared with wild-type controls; however, depletion of Treg cells in DKO mice abolished these protective effects. By contrast, adoptive transfer of Treg cells from DKO mice protected wild-type mice from ANGII-induced hypertension and target-organ damage.
In cultured CD4+CD25+ Treg cells from wild-type mice, ANGII infusion induced an increase in the mRNA expression of C3aR and C5aR and a decrease in the expression of FOXP3. Stimulation with CD3 and CD28 antibodies also downregulated FOXP3 expression in Treg cells from wild-type mice but not in those from DKO mice. In addition, the differentiation of DKO CD4+CD25− T cells into FOXP3+ Treg cells was increased in comparison to that of wild-type CD4+CD25− T cells. Based on these data, the researchers suggest that double knockout of C3aR and C5aR enhances the functions of Treg cells.
targeting C3aR and C5aR on Treg cells could be a novel strategy for the treatment of hypertension
Finally, the researcher report that the serum levels of C3a and C5a as well as C5aR expression in FOXP3+ Treg cells were increased in patients with hypertension compared with normotensive individuals. They conclude that “C3aR and C5aR play pivotal roles in [blood pressure] regulation and hypertension-related organ damage, likely through regulating Treg cell functions,” and suggest that targeting C3aR and C5aR on Treg cells could be a novel strategy for the treatment of hypertension.
References
Chen, X.-H. et al. Deficiency of complement C3a and C5a receptors prevents angiotensin II-induced hypertension via regulatory T cells. Circ. Res. https://doi.org/10.1161/CIRCRESAHA.117.312153 (2018)
Rights and permissions
About this article
Cite this article
Carney, E. Role of C3aR and C5aR in Treg cells. Nat Rev Nephrol 14, 214 (2018). https://doi.org/10.1038/nrneph.2018.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2018.18